The American company, Johnson & Johnson, said in a press release that it had decided to postpone the use of the corona vaccine in Europe.

The company indicated that it was aware of cases of blood clots after Johnson & Johnson was vaccinated.

In her statement, she continued: "In addition, we are studying these cases with the European health authorities. So we decided to postpone the use of our vaccine in Europe. "

The United States Food and Drug Administration (FDA) has recommended that the use of the new Johnson & Johnson anti - corona vaccine should be suspended after blood clots have been detected, and that data should be reviewed containing 6 reported cases of a rare and highly sensitive type of blood clot after receiving the vaccine.

In a joint statement with the United States Centers for Disease Control and Prevention (CDC), FDA explained that "the temporary suspension of the use of the Johnson & Johnson vaccine is important to ensure that the medical sector is aware of the possibility of such adverse complications, and to work on the required treatment for this type of blood clot."

The statement also revealed that, as of yesterday, more than 6.8 million doses of the vaccine had been distributed in the United States of America, adding that those negative cases are currently extremely rare.